Novo Nordisk’s weight loss drug has shown promising liver benefits in a new preclinical study, pointing to effects beyond just shedding pounds. Researchers found that the company’s GLP-1-based treatment improved liver health in mice, even when...
The Bajaj Group has announced its entry into India’s healthcare sector with an investment of ?2,000–?2,500 crore to build an integrated healthcare network. This move marks a major diversification for the long-established business grou...
The essential drugs price hike due to Iran war is starting to reflect in India’s pharmaceutical market, with reports indicating that prices of key medicines may rise by up to 5 percent in the near term.
India’s INR 10,000 crore startup fund boosts health tech and medtech startups, giving a strong push to innovation in critical healthcare areas. Announced as part of the government’s renewed funding strategy, the initiative is designed to channel...
Weight-loss injections are gaining popularity across India, often positioned as a simple and effective solution for obesity. But only 4 in 10 Indians See Big Weight-Loss Results. A study conducted at Max Super Speciality Hospital, involving 150...
The Centre is considering using the extensive India Post network to expand the reach of Jan Aushadhi Kendras and enable doorstep delivery of medicines. The move is aimed at improving access to affordable medicines in India, especially in rura...
Today news highlights a major shift in India's Global Capability Center ecosystem as ANSR launches a new MedTech GCC in India for a Fortune 100 healthcare company. The MedTech GCC in India is being positioned as a global innovation hub focused...
India’s pharmaceutical sector witnessed a steady flow of capital deployment, strategic investments, and funding-led expansion between March 30 and April 9, 2026, driven by global acquisition ambitions, domestic capacity building...
A Parliamentary panel has recommended major changes to how traditional medicine drugs are regulated in India, calling for the creation of a single, independent authority to oversee the Ayush sector regulation.
India has stepped up action against GLP-1 drug misuse as cheaper generic versions flood the market, raising safety concerns. The Drugs Controller General of India has launched nationwide audits and inspections to curb GLP-1 drug misuse and...
, CDSCO.jpg)